Marie Bleakley

Author PubWeight™ 14.60^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.	Blood	2010	2.59
2	IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response.	J Immunol	2005	2.44
3	Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities.	Blood	2007	2.16
4	Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia.	Clin Cancer Res	2009	1.74
5	Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.	J Clin Invest	2015	1.13
6	NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.	Cancer	2012	1.13
7	Adoptive transfer of allogeneic antigen-specific T cells.	Biol Blood Marrow Transplant	2006	1.04
8	Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia.	Br J Haematol	2006	1.00
9	Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen.	Blood	2012	0.99
10	Safety of early immunization against measles/mumps/rubella after bone marrow transplantation.	Blood	2002	0.75